{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:12:00Z","timestamp":1790082720554,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["140305164163"],"award-info":[{"award-number":["140305164163"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119882","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:56:48Z","timestamp":1788148608000},"page":"119882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mannose-decorated nanostructured lipid carriers improve the intracellular activity of antitubercular drugs against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"203","author":[{"given":"Leili","family":"Shokoohizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin Bahmani","family":"Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Torkamanasadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh Moayedi","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Gorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Ghaderkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Doosti","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-504X","authenticated-orcid":false,"given":"Seyed Mostafa","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119882_bib1","series-title":"Proteins in Mycobacterium Tuberculosis: Functions and Therapeutic Advances","first-page":"1","article-title":"Tuberculosis: an ongoing global threat","author":"Farnia","year":"2025"},{"key":"10.1016\/j.biopha.2026.119882_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.943545","article-title":"Drug resistant tuberculosis: implications for transmission, diagnosis, and disease management","volume":"12","author":"Liebenberg","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119882_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2025-019011","article-title":"Drug-resistant tuberculosis in war and complex emergencies: jeopardising progress towards TB elimination and antimicrobial resistance control\u2013a scoping review and perspective","volume":"11","author":"Monedero-Recuero","year":"2026","journal-title":"BMJ Glob. Health"},{"issue":"4","key":"10.1016\/j.biopha.2026.119882_bib4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/microorganisms13040722","article-title":"Innovative strategies for combating multidrug-resistant tuberculosis: advances in drug delivery systems and treatment","volume":"13","author":"Omoteso","year":"2025","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.biopha.2026.119882_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1134\/S1068162023603257","article-title":"Recent developments in structurally diverse anti-tubercular drug molecules and their molecular targets against Mycobacterium tuberculosis","volume":"51","author":"Alghamdi","year":"2025","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119882_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3934\/microbiol.2025045","article-title":"Mechanisms of antimicrobial resistance: from genetic evolution to clinical manifestations","volume":"11","author":"Nusrat","year":"2025","journal-title":"AIMS Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119882_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/microorganisms11030567","article-title":"What is the best vancomycin therapeutic drug monitoring parameter to assess efficacy? A critical review of experimental data and assessment of the need for individual patient minimum inhibitory concentration value","volume":"11","author":"Dalton","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2026.119882_bib8","article-title":"The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management","author":"Gopalaswamy","year":"2026","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119882_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.biopha.2026.119882_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2026.119882_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/ijms25031370","article-title":"Mannose ligands for mannose receptor targeting","volume":"25","author":"Paurevi\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119882_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1134\/S1068162022010150","article-title":"Mannose receptors of alveolar macrophages as a target for the addressed delivery of medicines to the lungs","volume":"48","author":"Zlotnikov","year":"2022","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119882_bib13","article-title":"Current advances in lipid-based drug delivery systems as nanocarriers for the management of female genital Tuberculosis","volume":"16","author":"Chavan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2026.119882_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jconrel.2024.08.029","article-title":"Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus aureus infections: In vitro and in vivo efficacy of a novel antibiotic","volume":"374","author":"Costabile","year":"2024","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biopha.2026.119882_bib15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/JCM.02268-10","article-title":"Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB\/RIF system","volume":"49","author":"Hillemann","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.biopha.2026.119882_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1435151","article-title":"Antibiotics-encapsulated nanoparticles as an antimicrobial agent in the treatment of wound infection","volume":"15","author":"Taheri","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119882_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.963318","article-title":"Effects of monosaccharide composition on quantitative analysis of total sugar content by phenol-sulfuric acid method","volume":"9","author":"Yue","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biopha.2026.119882_bib18","article-title":"Nanostructured lipid carriers co-loaded with doxycycline, gentamicin, and thymol for enhanced intracellular antibacterial activity against Brucella melitensis","volume":"616475","author":"Morovati Moez","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.biopha.2026.119882_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s13346-020-00815-3","article-title":"Nanoparticle-mediated macrophage targeting\u2014a new inhalation therapy tackling tuberculosis","volume":"11","author":"Makled","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119882_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00088-23","article-title":"Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments","volume":"36","author":"Suman","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2026.119882_bib21","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3390\/nano11081984","article-title":"Targeting intracellular mycobacteria using nanosized niosomes loaded with antibacterial agents","volume":"11","author":"Slavin","year":"2021","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/j.biopha.2026.119882_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119882_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119882_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119882_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biopha.2026.119882_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkg477","article-title":"Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis","volume":"52","author":"Pandey","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2026.119882_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2016.04.012","article-title":"The formulation of nanomedicines for treating tuberculosis","volume":"102","author":"Costa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119882_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119882_bib29","article-title":"Exploitation of the macrophage mannose receptor (CD206) in infectious disease diagnostics and therapeutics","volume":"10","author":"Azad","year":"2014","journal-title":"J. Cytol. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119882_bib30","series-title":"WHO Operational Handbook on Tuberculosis. Module 5: Management of Tuberculosis in Children and Adolescents","author":"Organization","year":"2022"},{"issue":"24","key":"10.1016\/j.biopha.2026.119882_bib31","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.2217\/nnm-2017-0248","article-title":"Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment","volume":"12","author":"Vieira","year":"2017","journal-title":"Nanomedicine"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:56:11Z","timestamp":1790081771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S0753332226009182"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119882","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mannose-decorated nanostructured lipid carriers improve the intracellular activity of antitubercular drugs against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119882"}}